510(k) Report

510(k) · Cleared

Cleared

OPXION Optical Skin Viewer (OPXSV1-01F)

K242924510(k) TraditionalCleared Jun 23, 2025272-day reviewClass II21 CFR 892.1560

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Opxion Technology, Inc. · NQQ System, Imaging, Optical Coherence Tomography (Oct)

Cleared on Jun 23, 2025 as substantially equivalent to K093520 (Michelson Diagnostics, Ltd., 2010) after a 272-day review. Its family tree reaches back 1 generation to 2010.

Decided
Jun 23, 2025
Review
272 days
Class
Class II
Product code
NQQ
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K093520 (2010). No later device cites it as a predicate yet.

K093520 · Vivosight Topical Oct System · Michelson Diagnostics, Ltd. · 20102010201520202025
  1. Root · 1 generation backK093520 Vivosight Topical Oct SystemMichelson Diagnostics, Ltd. · 2010
  2. This deviceK242924 OPXION Optical Skin Viewer (OPXSV1-01F)Opxion Technology, Inc. · 2025
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K093520Vivosight Topical Oct SystemMichelson Diagnostics, Ltd.2010—
0 (this device)K242924OPXION Optical Skin Viewer (OPXSV1-01F)Opxion Technology, Inc.2025—
FIG. 1 — Lineage of K242924, 2010–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NQQ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NQQ device

  1. #1 K251730 LIA Console (542-7)score 16.2 · 20 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K093520Vivosight Topical Oct System
Summary page 6
…Regulation Name: Ultrasonic pulsed echo imaging system 510(k) Number: K093520 510(k) Submitter: Michelson Diagnostics Ltd Device Class: Class I…
Michelson Diagnostics, Ltd.2010—

Also cleared against K093520: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 3 other devices also cite its predicate K093520.

How does its category compare?

All NQQ devices

NQQ System, Imaging, Optical Coherence Tomography (Oct): FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · NQQ

8in 2025

2010: 32011: 22012: 12013: 22014: 22015: 52016: 52017: 12018: 22019: 32020: 22021: 22023: 32024: 22025: 82026 (partial year): 1
2007high 8 (2025) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NQQ

146in 2025

2010: 82 days median2015: 91 days median2016: 91 days median2019: 84 days median2023: 86 days median2025: 146 days median
2007high 146 (2025) · low 82 (2010)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NQQ

1in 2011

2010: 12011: 1
2007high 1 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NQQ

2in 2025

2011: 22012: 52013: 32014: 12015: 32016: 22017: 32018: 42019: 62020: 42021: 32022: 42023: 62024: 62025: 2
2007high 6 (2019) · low 0 (2007)2025

MAUDE reports naming product code NQQ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
201038210
20112—12
20121—05
20132—03
20142—01
201559103
201659102
20171—03
20182—04
201938406
20202—04
20212—03
20220—04
202338606
20242—06
2025814602
20261—0—

What is it indicated for?

OPXION Optical Skin Viewer is a non-invasive imaging system intended to be used for real-time visualization of the external tissues of the human body. The two-dimensional, cross-sectional, three-dimensional, and en-face images of tissue microstructures can be obtained.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K242924: OPXION Optical Skin Viewer (OPXSV1-01F).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K242924

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026